Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,625–1,632 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Elicio Therapeutics Inc. ANG-3070 Idiopathic Pulmonary Fibrosis Phase 2 Trial Discontinued oral Respiratory
Elicio Therapeutics Inc. ELI-002 (AMPLIFY-201) Solid Tumors Phase 2 Ongoing Subcutaneous Oncology
Elicio Therapeutics Inc. ANG-3070 - (JUNIPER) Primary proteinuric kidney diseases Phase 2 Trial Discontinued oral N/A
Elicio Therapeutics Inc. ANG-3777 Acute kidney injury (AKI) / Delayed Graft Function Phase 3 Trial Discontinued Intravenous N/A
Elicio Therapeutics Inc. ELI-002 - (AMPLIFY-7P) mKRAS-driven cancers Phase 2 Data Released Subcutaneous Oncology
Elicio Therapeutics Inc. ANG-3777 - (GUARD) Acute Kidney Injury associated with cardiac surgery Phase 2 Trial Discontinued Intravenous N/A
Eloxx Pharmaceuticals Inc. ELX-02 Cystinosis Phase 2 Intravenous Genetic Disorder
Eloxx Pharmaceuticals Inc. ELX-02 Alport syndrome Phase 2 Intravenous Genetic Disorder